EHS Specialist 2 at Eikon Therapeutics

Millbrae, California, United States

Eikon Therapeutics Logo
Not SpecifiedCompensation
Mid-level (3 to 4 years)Experience Level
Full TimeJob Type
UnknownVisa
Biopharmaceuticals, BiotechnologyIndustries

Requirements

  • Bachelor’s degree in chemistry and a minimum of 2 years relevant EHS experience working with chemical waste, handling hazardous materials, or working as a generalist member in an EHS organization
  • Experience working in a regulated environment such as biopharma, medical device, clinical lab, diagnostics, vaccines
  • Knowledge of California and Federal regulations related to chemicals, biological materials, power tools/machine, lasers, injury prevention, emergency response
  • Familiarity with hazardous waste and medical waste management requirements, including federal, state, and local laws and regulations pertaining to proper handling, packaging, transportation, and disposal of waste
  • Strong verbal communication skills and ability to connect with employees at all levels of the organization (associates, managers, leaders). Able to effectively speak to small groups

Responsibilities

  • Act as main point of contact for EHS vendors; coordinate vendor work and facilitate resolution of EHS issues with lab users
  • Perform regular walk-throughs and inspection of lab operations. Ensure proper safety devices, signage and all relevant safety related documentation are in place and updated
  • Maintain individual DOT hazmat shipping certifications. As requested, provide guidance and support to shipping personnel preparing hazmat packages
  • Manage submittals and filings associated with Eikon’s EPA ID (federal and state small quantity generator) and with the local CUPA
  • Ensure retention and organization of regulated waste disposal documentation
  • Assist with periodic review and update of EHS program documents as necessary
  • Serve as point of contact for regulatory inspectors
  • Manage the EHS Training system and help develop innovative training materials to educate employees on safe work practices. Minimize the risk of ergonomic injury to employees through awareness, education, and early intervention
  • Assist in maintaining enterprise EHS software systems (e.g., VelocityEHS, Alert Media) and manage Eikon’s OSHA 300 log
  • Coordinate exposure monitoring using standard industrial hygiene equipment and techniques. Includes noise monitoring, chemical exposure monitoring
  • Help support the site in emergency situations

Skills

EHS Compliance
Chemical Safety
Waste Management
Biosafety
Laser Safety
Emergency Response
Lab Inspections
Vendor Management

Eikon Therapeutics

Biotech startup developing innovative medicines

About Eikon Therapeutics

Eikon Therapeutics focuses on discovering and developing new medicines in the pharmaceutical industry. The company employs advanced technologies to study biological systems, aiming to identify new drug targets by examining the dynamic aspects of biology rather than just static chemical processes. Their team consists of diverse professionals, including data scientists, chemists, and engineers, which allows them to combine science and engineering to create new therapies that aim to improve and extend life. A key feature of Eikon's approach is their proprietary single-molecule tracking (SMT) platform, which enables rapid visualization of protein movements in living cells. This technology, along with artificial intelligence and automation, allows for precise inventorying of molecular interactions. Eikon Therapeutics targets patients with serious diseases who need effective treatments, generating revenue through the development and commercialization of their therapies.

Hayward, CaliforniaHeadquarters
2019Year Founded
$750.8MTotal Funding
SERIES_CCompany Stage
AI & Machine Learning, BiotechnologyIndustries
201-500Employees

Benefits

401(k) Company Match
Medical (premiums covered by Eikon at 95%)
Dental Insurance
Vision Insurance
Mental Health Support
Unlimited Paid Time Off
Paid Holidays
Life Insurance
Enhanced Parental Leave
Daily subsidized lunch program

Risks

Competition from biotech unicorns like Abogen Biosciences is increasing.
Integrating new clinical-stage assets may delay drug development timelines.
Reliance on SMT technology risks obsolescence from emerging molecular biology technologies.

Differentiation

Eikon uses proprietary single-molecule tracking for real-time protein movement analysis.
The company integrates AI and automation for large-scale molecular interaction studies.
Eikon's diverse team combines expertise in science, engineering, and technology.

Upsides

Growing interest in SMT technology boosts Eikon's drug discovery potential.
Partnerships with AI firms enhance Eikon's drug candidate identification.
Rising demand for precision medicine aligns with Eikon's focus on dynamic biology.

Land your dream remote job 3x faster with AI